3-(2-Bromoethoxy)benzonitrile, 95.0%, 500mg

2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-, 25mg

Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-, 95%, 25g

Tert-butyl n-(1,3-dioxaindan-4-yl)carbamate, 95+%, 250mg

Nitazoxanide, 95.0%, 25g

Cesium bromide, 99%, 25g

4-Methyl-3-nitroaniline, min. 99%, for synthesis, 50 g, glass packaging

Methyl 4,6-dichloro-5-nitronicotinate, 97%, 5g

cis-9,10-Octadecanamide, 65%, 500g

1-[1-(3-methoxyphenyl)-1H-pyrazol-4-yl]-N-methylmethanamine, 95.0%, 25g

3-Bromo-4',4''-dimethyltriphenylamine>97.0%(GC)1g

5-Methylthiophene-3-boronic acid, 95+%, 5g

4-Toluenesulfonylacetonitrile, 97.0%, 100g